刚刚消息 - 据报道，阿斯利康正在谈判与美国百时美施贵宝合并，此交易将创建一个全球最大的制药集团之一，估值近4000亿美元 — FT

JUST IN - AstraZeneca reportedly in talks to combine with U.S. Bristol Myers Squibb in a deal that would create one of the world’s biggest pharmaceutical groups, valued at nearly $400 billion — FT